Serum sought approval for the use of the corona vaccine, becoming the first indigenous company

New Delhi: The Serum Institute on Sunday became the first indigenous company in India to apply to the Drug Controller General of India (DCGI) for formal approval for emergency use of the Oxford Covishield vaccine. Official sources gave this information.

The company has requested that the approval be given considering the medical needs and the wider public interest during the Corona crisis. Earlier on Saturday, the Indian unit of US-based pharmaceutical company Pfizer had applied to DCGI for formal approval for emergency use of the Covid-19 vaccine.

Pfizer has made the request for approval in India after the Covid-19 vaccine was approved in Britain and Bahrain. On Sunday, SII, in collaboration with the Indian Council of Medical Research (ICMR), conducted the third phase of clinical trials of Oxford’s Covid-19 vaccine Covishield in various parts of the country.

Minister Corona positive even after vaccination? Explanation of Bharat Biotech

Four data from clinical trials have shown that Covishield has been shown to be highly effective in patients with corona symptoms and especially in severe corona patients. Two of the four test data relate to the UK and one each to India and Brazil, sources said.

Coronavirus Vaccine: Great news, Pfizer seeks vaccine approval

The vaccine is 90 percent effective

The covina vaccine 90 Covishield tested was 90 percent effective. The vaccine will soon be available to everyone. SII CEO Adar Punawala has also claimed that a deal of Rs 100 million has been struck with AstraZeneca. At least 100 million doses of Covishield will be available by January and hundreds of millions of doses will be ready by the end of February, Adar Punawala said.